BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tsujimoto T, Kawaratani H, Kitazawa T, Yoshiji H, Fujimoto M, Uemura M, Fukui H. Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138. World J Gastroenterol 2009; 15(44): 5533-5540 [PMID: 19938191 DOI: 10.3748/wjg.15.5533]
URL: https://www.wjgnet.com/1007-9327/full/v15/i44/5533.htm
Number Citing Articles
1
Kirstine S. Tølbøl, Birgit Stierstorfer, Jörg F. Rippmann, Sanne S. Veidal, Kristoffer T. G. Rigbolt, Tanja Schönberger, Matthew P. Gillum, Henrik H. Hansen, Niels Vrang, Jacob Jelsing, Michael Feigh, Andre Broermann. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2019; 64(5): 1238 doi: 10.1007/s10620-018-5395-7
2
Tatsuhiro Tsujimoto, Hideto Kawaratani, Toshiyuki Kitazawa, Masahito Uemura, Hiroshi Fukui. Innate Immune Reactivity of the Ileum–Liver Axis in Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2012; 57(5): 1144 doi: 10.1007/s10620-012-2073-z
3
Yaron Ilan. Immune Therapy for Nonalcoholic SteatohepatitisJournal of Clinical Gastroenterology 2013; 47(4): 298 doi: 10.1097/MCG.0b013e31827873dc
4
Jing Liu, Zhen-jie Zhuang, Dong-xue Bian, Xiao-jie Ma, Yun-hao Xun, Wen-jun Yang, Yan Luo, Yin-lan Liu, Ling Jia, Yan Wang, Ming-li Zhu, De-wei Ye, Gang Zhou, Guo-qiang Lou, Jun-ping Shi. Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in miceClinical and Experimental Pharmacology and Physiology 2014; 41(7): 482 doi: 10.1111/1440-1681.12241
5
M I Koukourakis. Radiation damage and radioprotectants: new concepts in the era of molecular medicineThe British Journal of Radiology 2012; 85(1012): 313 doi: 10.1259/bjr/16386034
6
Y. TORINIWA, M. MURAMATSU, Y. ISHII, E. RIYA, K. MIYAJIMA, S. OHSHIDA, K. KITATANI, S. TAKEKOSHI, T. MATSUI, S. KUME, T. YAMADA, T. OHTA. Pathophysiological Characteristics of Non-Alcoholic Steatohepatitis-Like Changes in Cholesterol-Loaded Type 2 Diabetic RatsPhysiological Research 2018; : 601 doi: 10.33549/physiolres.933784
7
Masahiko Matsumoto, Natsuko Hada, Yoshiyuki Sakamaki, Akiko Uno, Toshihiko Shiga, Chiaki Tanaka, Tsuneo Ito, Asao Katsume, Masayuki Sudoh. An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitisInternational Journal of Experimental Pathology 2013; 94(2): 93 doi: 10.1111/iep.12008
8
Hideto Kawaratani, Tatsuhiro Tsujimoto, Toshiyuki Kitazawa, Hitoshi Yoshiji, Masahito Uemura, Hiroshi Fukui. Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease modelJournal of Gastroenterology and Hepatology 2011; 26(4): 775 doi: 10.1111/j.1440-1746.2011.06658.x